Pharsight Hosts European PKS User Meeting

Second Annual European Meeting to be Held In Paris 


MOUNTAIN VIEW, Calif., May 23  /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that it will host its second Pharsight(R) Knowledgebase Server(TM) (PKS(TM)) European User Group Meeting on May 28 and 29, 2008 at the Hotel Concorde La Fayette, Paris, France.

The meeting provides an environment for industry scientists and developers to discuss challenges and advances in regulatory compliant PK/PD ("pharmacokinetic and pharmacodynamic") data management. Case studies will be presented by industry attendees to illustrate their use of PKS and the decisive impact the software has had on facilitating improved productivity in their drug development processes. More information is available by emailing .

"Our expanding European PKS user base has requested additional opportunities to meet and discuss developments in compliant, high-productivity PK/PD data management," said Shawn O'Connor, Pharsight president, CEO and chairman. "These meetings allow PKS users to benefit from the experience of their peers and allow Pharsight engineers to maintain close contact with our clientele."

About PKS

PKS is a high-productivity, regulatory-compliant enterprise data repository that manages clinical pharmacology data. PKS enables pharmaceutical and biotechnology companies to better manage and control preclinical and clinical PK/PD data and analyses, thus supporting higher modeling productivity as called for in the FDA's Critical Path Initiative. The FDA is using PKS under a Cooperative Research and Development Agreement (CRADA).  Companies also use PKS to build PK/PD data management architecture that complies with the FDA's regulation 21 CFR Part 11, which has set new standards for computer system validation and usage. PKS is directly integrated with WinNonlin(R) Enterprise(TM), Pharsight's industry leading PK/PD modeling and analysis tool for state-of-the-art modeling and analyses, and supports direct access to any ODBC capable data source. PKS also supports analysis with leading tools such as NONMEM(R) and SAS(R).

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com/.

Registered Trademarks and Trademarks

Pharsight, Pharsight Knoweledgebase Server, PKS, WinNonlin, and WinNonlin Enterprise are trademarks or registered trademark of Pharsight Corporation. All other brand or product names mentioned in this document are trademarks or registered trademarks of their respective holders. 

DATASOURCE: Pharsight Corporation



CONTACT:  Investors, Douglas Sherk or Matthew Selinger, [phone],

or Media, Steve DiMattia or Donald Takaya, [phone], all of EVC Group,

Inc. for Pharsight Corporation



Web site:  http://www.pharsight.com/ 

Copyright